Olaparib 150mg Tablets – Trusted PARP Inhibitor for Targeted Cancer Therapy
Olaparib 150mg Tablets are a prescription anticancer medication used in targeted therapy for specific types of cancers. It belongs to the PARP inhibitor class and is widely used under oncology supervision for maintenance treatment and precision cancer care.
Cordium Pharmaceuticals Pvt Ltd, India, is a reliable global exporter and supplier of high-quality Olaparib 150mg Tablets, ensuring fast international delivery to:
United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Medical Uses of Olaparib 150mg Tablets
Olaparib is commonly prescribed for:
Ovarian cancer (maintenance therapy)
Breast cancer (BRCA-mutated cases)
Fallopian tube cancer
Primary peritoneal cancer
Prostate cancer (selected cases)
It works by blocking cancer cell DNA repair, slowing or stopping tumor growth.
Recommended Dosage
Dosage is strictly prescribed by an oncologist
Commonly taken twice daily (every 12 hours)
Can be taken with or without food
Swallow whole with water; do not crush or chew
⚠️ Dosage may vary based on patient condition, cancer type, and medical evaluation.
Possible Side Effects
Some patients may experience:
Nausea or vomiting
Fatigue or weakness
Anemia (low red blood cells)
Loss of appetite
Diarrhea
Headache
Low white blood cell count
👉 Regular blood monitoring is recommended during treatment.
Global Export & Supply by Cordium Pharmaceuticals Pvt Ltd
We ensure:
GMP-certified pharmaceutical manufacturing standards
Secure packaging & cold-chain compliance (if required)
Bulk export supply capability
Fast worldwide shipping support
Regulatory documentation assistance
We serve hospitals, distributors, oncology clinics, and licensed pharma importers globally.
Contact for Export Enquiry
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
